Sandbox Reserved 1237
From Proteopedia
(Difference between revisions)
Line 5: | Line 5: | ||
== Introduction == | == Introduction == | ||
- | Slx-2 was discovered in 1977 by Konowalchuki, Speirs, and Stavric in filtrate cultures of Escherichia coli. Due to its ability to affect African Green monkey kidney cells (Vero lineage), it it was first known as verotoxin. The protein was later found to be analogous to A5B-type Shiga toxin produced by Shigella dysenteriae, and was thus was also given the name Shiga-like toxin. Due to its role in hemolytic-uremic syndrome, a disease characterized by hemolytic anemia, kidney failure, and thrombocytopenia, this protein has been a topic of immunological research in recent years. Unlike their true-Shiga relatives, verotoxins are not heat-stable nor heat-labile, although their method of action remains relatively similar in regarding their role as an N-glycosidase. | + | Slx-2 was discovered in 1977 by Konowalchuki, Speirs, and Stavric in filtrate cultures of ''Escherichia coli''. Due to its ability to affect African Green monkey kidney cells (Vero lineage), it it was first known as verotoxin. The protein was later found to be analogous to A5B-type Shiga toxin produced by ''Shigella dysenteriae'', and was thus was also given the name Shiga-like toxin. Due to its role in hemolytic-uremic syndrome, a disease characterized by hemolytic anemia, kidney failure, and thrombocytopenia, this protein has been a topic of immunological research in recent years. Unlike their true-Shiga relatives, verotoxins are not heat-stable nor heat-labile, although their method of action remains relatively similar in regarding their role as an N-glycosidase. |
== Mechanism of Action == | == Mechanism of Action == | ||
- | Once ingested, enterohemorrhagic Escherichia coli (EHEC), such as serotype O157:H7, release verotoxin into the intestinal tract. The verotoxin B subunits bind to receptors on the intestinal, renal cell, or neuron membrane known as glycolipid globotriaosylceramides. This glycolipid, also known as Gb3, is reported as the receptor for both Slx-1 and Slx-2. The analogous stx-2’s binding to Gb3 is heavily dependent on the presence of residues, such as phosphatidylcholine or glycolipid galactosylceramide, upon ceramide portion of Gb3, as well as the lipid environment (i.e. the presence of cholesterol). Both verotoxins can also bind Gb4, but Stx-2 cannot bind. Although it is speculative, it is suggested as possible that cholesterol may “form hydrogen bonds with the ceramide on glycolipids, leading to conformational changes that make cells more susceptible…”. This is the case for HIV, but has not been shown for verotoxin to date. | + | Once ingested, enterohemorrhagic ''Escherichia coli'' (EHEC), such as serotype O157:H7, release verotoxin into the intestinal tract. The verotoxin B subunits bind to receptors on the intestinal, renal cell, or neuron membrane known as glycolipid globotriaosylceramides. This glycolipid, also known as Gb3, is reported as the receptor for both Slx-1 and Slx-2. The analogous stx-2’s binding to Gb3 is heavily dependent on the presence of residues, such as phosphatidylcholine or glycolipid galactosylceramide, upon ceramide portion of Gb3, as well as the lipid environment (i.e. the presence of cholesterol). Both verotoxins can also bind Gb4, but Stx-2 cannot bind. Although it is speculative, it is suggested as possible that cholesterol may “form hydrogen bonds with the ceramide on glycolipids, leading to conformational changes that make cells more susceptible…”. This is the case for HIV, but has not been shown for verotoxin to date. |
No work has yet been done on specific Slx-2 binding to Gb3, but it can be assumed due to the homology present between the two, as well as their shared receptor, that the mechanisms are roughly the same. The binding of the B subunit to G3b occurs at one to three receptor sites on the subunits, the third of which is has a lower affinity than the first two. As the B subunits bind with high affinity, the cluster of verotoxin expands laterally across the membrane, causing it to invaginate with or without the assistance of cellular tubules such as actin or dynamin. Such invagination give way to the formation of vesicles which transport the toxins into the cell. Once there, the A subunit is cleaved by the action of furin to form A1 and A2. A2 keeps A1 bound to the B pentamer, while A1 carries out the endohydrolysis of the N-glycosidic bond at a specific adenosine on the 28S rRNA unit of a 60S ribosome. This halts protein synthesis, killing the cell. With Stx, the dead cells release cytokines and chemokines, which play a role in platelet activation. Stx also inactivates ADAMTS13, which is involved in cleaving a protein that is involved in blood clotting, thus increasing the level of platelet activation further, eventually leading to the formation of microthrombi. | No work has yet been done on specific Slx-2 binding to Gb3, but it can be assumed due to the homology present between the two, as well as their shared receptor, that the mechanisms are roughly the same. The binding of the B subunit to G3b occurs at one to three receptor sites on the subunits, the third of which is has a lower affinity than the first two. As the B subunits bind with high affinity, the cluster of verotoxin expands laterally across the membrane, causing it to invaginate with or without the assistance of cellular tubules such as actin or dynamin. Such invagination give way to the formation of vesicles which transport the toxins into the cell. Once there, the A subunit is cleaved by the action of furin to form A1 and A2. A2 keeps A1 bound to the B pentamer, while A1 carries out the endohydrolysis of the N-glycosidic bond at a specific adenosine on the 28S rRNA unit of a 60S ribosome. This halts protein synthesis, killing the cell. With Stx, the dead cells release cytokines and chemokines, which play a role in platelet activation. Stx also inactivates ADAMTS13, which is involved in cleaving a protein that is involved in blood clotting, thus increasing the level of platelet activation further, eventually leading to the formation of microthrombi. | ||
Line 21: | Line 21: | ||
== Treatments == | == Treatments == | ||
- | The use of antibiotics to treat E. coli O157:H7 related diseases is extremely controversial, because there is evidence that certain antibiotics such as polymyxin B, trimethoprime / sulphamethoxazole, ciprofloxacin, cefixime, and tetracycline can increase verotoxin production, worsening the issue and increasing mortality rates. However, some antibotics such as quinolones and fosfomycin, may prevent the development of haemolytic uraemic syndrome or thrombotic thrombocytopenic purpura. The issue, like any case dealing with antibiotics, is ensuring that the bacteria do not become resistant to the few plausible treatment options that we seems to have. | + | The use of antibiotics to treat ''E. coli'' O157:H7 related diseases is extremely controversial, because there is evidence that certain antibiotics such as polymyxin B, trimethoprime / sulphamethoxazole, ciprofloxacin, cefixime, and tetracycline can increase verotoxin production, worsening the issue and increasing mortality rates. However, some antibotics such as quinolones and fosfomycin, may prevent the development of haemolytic uraemic syndrome or thrombotic thrombocytopenic purpura. The issue, like any case dealing with antibiotics, is ensuring that the bacteria do not become resistant to the few plausible treatment options that we seems to have. |
== Relevance == | == Relevance == | ||
Line 33: | Line 33: | ||
== Evolution == | == Evolution == | ||
- | Subunits A and B are encoded for by (stxA2 + stx2A + L0103) and (stxB2 + stx2B + L0104) respectively. It has been suggested by some that, due to the more appropriate phylogenetic placement of Shigella as a subgenus of Escherichia rather than as its own genus, it is possible that Stx could have been transduced into E. coli by a toxin-converting lambdoid bacteriophage, such as H-19B or 933W. This would explain the high conservation of amino acid sequences in functionally relevant (and otherwise structural) portions of the subunits. | + | Subunits A and B are encoded for by (stxA2 + stx2A + L0103) and (stxB2 + stx2B + L0104) respectively. It has been suggested by some that, due to the more appropriate phylogenetic placement of ''Shigella'' as a subgenus of ''Escherichia'' rather than as its own genus, it is possible that Stx could have been transduced into ''E. coli'' by a toxin-converting lambdoid bacteriophage, such as H-19B or 933W. This would explain the high conservation of amino acid sequences in functionally relevant (and otherwise structural) portions of the subunits. |
[[Image:http://mostlyscience.com/wp-content/uploads/2014/09/rsz_viveknarotammolecule.jpg]] | [[Image:http://mostlyscience.com/wp-content/uploads/2014/09/rsz_viveknarotammolecule.jpg]] |
Revision as of 07:32, 1 May 2017
This Sandbox is Reserved from Jan 17 through June 31, 2017 for use in the course Biochemistry II taught by Jason Telford at the Maryville University, St. Louis, USA. This reservation includes Sandbox Reserved 1225 through Sandbox Reserved 1244. |
To get started:
More help: Help:Editing |
Verotoxin-2
|